Literature DB >> 19281872

The n-hexane and chloroform fractions of Piper betle L. trigger different arms of immune responses in BALB/c mice and exhibit antifilarial activity against human lymphatic filarid Brugia malayi.

Meghna Singh1, Shilpy Shakya, Vishal Kumar Soni, Anil Dangi, Nikhil Kumar, Shailja-Misra Bhattacharya.   

Abstract

Modulation of immune functions by using herbal plants and their products has become fundamental regime of therapeutic approach. Piper betle Linn. (Piperaceae) is a widely distributed plant in the tropical and subtropical regions of the world and has been attributed as traditional herbal remedy for many diseases. We have recently reported the antifilarial and antileishmanial efficacy in the leaf extract of Bangla Mahoba landrace of P. betle which is a female plant. The present report describes the in vivo immunomodulatory efficacy of the crude methanolic extract and its n-hexane, chloroform, n-butanol fractions of the female plant at various dose levels ranging between 0.3 and 500 mg/kg in BALB/c. Attempts were also made to observe antifilarial activity of the active extracts and correlate it with the antigen specific immune responses in another rodent Mastomys coucha infected with human lymphatic filarial parasite Brugia malayi. The crude methanol extract and n-hexane fraction were found to potentiate significant (p<0.001) enhancement of both humoral (plaque forming cells, hemagglutination titre) as well as cell-mediated (lymphoproliferation, macrophage activation, delayed type hypersensitivity) immune responses in mice. The flow cytometric analysis of splenocytes of treated mice indicated enhanced population of T-cells (CD4(+), CD8(+)) and B-cells (CD19(+)). The n-hexane fraction (3 mg/kg) was found to induce biased type 2 cytokine response as revealed by increased IL-4(+) and decreased IFN-gamma(+) T-cell population while the chloroform fraction (10 mg/kg) produced a predominant type 1 cytokines. Crude methanolic extract (100 mg/kg) demonstrated a mixed type 1 and type 2 cytokine responses thus suggesting a remarkable immunomodulatory property in this plant. The induction of differential T-helper cell immune response appears ideal to overcome immunosuppression as observed in case of lymphatic, filarial Brugia malayi infection which may also be extended to other infections as well.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19281872     DOI: 10.1016/j.intimp.2009.02.012

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  16 in total

Review 1.  Potential of Piper spp. as a source of new compounds for the leishmaniases treatment.

Authors:  Juliana Figueiredo Peixoto; Ygor Jessé Ramos; Davyson de Lima Moreira; Carlos Roberto Alves; Luiz Filipe Gonçalves-Oliveira
Journal:  Parasitol Res       Date:  2021-07-10       Impact factor: 2.289

Review 2.  Betelvine (Piper betle L.): A comprehensive insight into its ethnopharmacology, phytochemistry, and pharmacological, biomedical and therapeutic attributes.

Authors:  Protha Biswas; Uttpal Anand; Suchismita Chatterjee Saha; Nishi Kant; Tulika Mishra; Harison Masih; Ananya Bar; Devendra Kumar Pandey; Niraj Kumar Jha; Madhumita Majumder; Neela Das; Vijaykumar Shivaji Gadekar; Mahipal S Shekhawat; Manoj Kumar; Jarosław Proćków; José M Pérez de la Lastra; Abhijit Dey
Journal:  J Cell Mol Med       Date:  2022-05-02       Impact factor: 5.295

3.  In vitro antifungal activity of hydroxychavicol isolated from Piper betle L.

Authors:  Intzar Ali; Farrah G Khan; Krishan A Suri; Bishan D Gupta; Naresh K Satti; Prabhu Dutt; Farhat Afrin; Ghulam N Qazi; Inshad A Khan
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-02-03       Impact factor: 3.944

4.  Characteristic differences in metabolite profile in male and female plants of dioecious Piper betle L.

Authors:  Vikas Bajpai; Renu Pandey; Mahendra Pal Singh Negi; K Hima Bindu; Nikhil Kumar; Brijesh Kumar
Journal:  J Biosci       Date:  2012-12       Impact factor: 1.826

5.  Cofactor independent phosphoglycerate mutase of Brugia malayi induces a mixed Th1/Th2 type immune response and inhibits larval development in the host.

Authors:  Prashant K Singh; Susheela Kushwaha; Ajay K Rana; Shailja Misra-Bhattacharya
Journal:  Biomed Res Int       Date:  2014-07-01       Impact factor: 3.411

6.  Piper betle extracts exhibit antitumor activity by augmenting antioxidant potential.

Authors:  Badrul Alam; Rajib Majumder; Shahina Akter; Sang-Han Lee
Journal:  Oncol Lett       Date:  2014-11-25       Impact factor: 2.967

7.  Piper betle shows antioxidant activities, inhibits MCF-7 cell proliferation and increases activities of catalase and superoxide dismutase.

Authors:  Noor Nazirahanie Abrahim; M S Kanthimathi; Azlina Abdul-Aziz
Journal:  BMC Complement Altern Med       Date:  2012-11-15       Impact factor: 3.659

8.  Natural products as a source for treating neglected parasitic diseases.

Authors:  Dieudonné Ndjonka; Ludmila Nakamura Rapado; Ariel M Silber; Eva Liebau; Carsten Wrenger
Journal:  Int J Mol Sci       Date:  2013-02-06       Impact factor: 5.923

9.  Exoproteome and secretome derived broad spectrum novel drug and vaccine candidates in Vibrio cholerae targeted by Piper betel derived compounds.

Authors:  Debmalya Barh; Neha Barve; Krishnakant Gupta; Sudha Chandra; Neha Jain; Sandeep Tiwari; Nidia Leon-Sicairos; Adrian Canizalez-Roman; Anderson Rodrigues dos Santos; Syed Shah Hassan; Síntia Almeida; Rommel Thiago Jucá Ramos; Vinicius Augusto Carvalho de Abreu; Adriana Ribeiro Carneiro; Siomar de Castro Soares; Thiago Luiz de Paula Castro; Anderson Miyoshi; Artur Silva; Anil Kumar; Amarendra Narayan Misra; Kenneth Blum; Eric R Braverman; Vasco Azevedo
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

10.  Antioxidant, analgesic and anti-inflammatory activities of the methanolic extract of Piper betle leaves.

Authors:  Badrul Alam; Fahima Akter; Nahida Parvin; Rashna Sharmin Pia; Sharmin Akter; Jesmin Chowdhury; Kazi Sifath-E-Jahan; Ekramul Haque
Journal:  Avicenna J Phytomed       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.